Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma

MLA

Jonathan Polikoff, et al. “Phase II Trial of Bevacizumab and Temozolomide for Treatment of Elderly Patients with Newly Diagnosed Glioblastoma.” Journal of Clinical Oncology, vol. 38, May 2020, p. 2540. EBSCOhost, https://doi.org/10.1200/jco.2020.38.15_suppl.2540.

APA

Jonathan Polikoff, Fabio M. Iwamoto, William H. Yong, Donna Molaie, Mei Leng, Richard M. Green, Emese Filka, Thien Nguyen, Liz Spier, Hye Hyun Bahng, Benjamin M. Ellingson, Andrew B. Lassman, Albert Lai, Timothy F. Cloughesy, Stacey Green, Whitney B. Pope, & Phioanh L. Nghiemphu. (2020). Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma. Journal of Clinical Oncology, 38, 2540. https://doi.org/10.1200/jco.2020.38.15_suppl.2540

Chicago

Jonathan Polikoff, Fabio M. Iwamoto, William H. Yong, Donna Molaie, Mei Leng, Richard M. Green, Emese Filka, et al. 2020. “Phase II Trial of Bevacizumab and Temozolomide for Treatment of Elderly Patients with Newly Diagnosed Glioblastoma.” Journal of Clinical Oncology 38 (May): 2540. doi:10.1200/jco.2020.38.15_suppl.2540.